Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dopaminergic Modulation of Frontostriatal Function With a Dopamine Agonist and COMT Inhibitor

NCT02929485 is registered in ClinicalTrials.gov with University of California, Berkeley as lead sponsor.

NCT NCT02929485
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02929485 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dopaminergic Modulation of Frontostriatal Function With a Dopamine Agonist and COMT Inhibitor
Lead sponsor
University of California, Berkeley
Phase
Phase 4
Overall status
Withdrawn
Start date
July 31, 2013
Completion date
January 31, 2018
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

addiction